Indication

Neonatal pneumonia

Neonatal pneumonia is an acute lower respiratory tract infection affecting newborn infants within the first 28 days of life. Read more about Neonatal pneumonia

140 drugs 73 manufacturers

Advertisement

Drugs that treat it

Common Neonatal pneumonia therapies.

Showing 10–18 of 140 drugs

Filter & compare in the drug finder →Opens the drug finder with Neonatal pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Neonatal pneumonia.

Neonatal pneumonia is an acute lower respiratory tract infection affecting newborn infants within the first 28 days of life.

It can be categorized as congenital, early-onset (typically acquired perinatally via ascending amniotic infection or aspiration during delivery), or late-onset (usually nosocomial or community-acquired).

Pathophysiologically, pathogen invasion triggers alveolar inflammation, impaired gas exchange, and surfactant dysfunction, which frequently presents as respiratory distress—including tachypnea, grunting, retractions, and hypoxemia—or as part of a generalized systemic sepsis syndrome.

Common causative organisms include group B *Streptococcus*, enteric Gram-negative bacilli such as *Escherichia coli*, and other nosocomial or viral pathogens.

Personalize your experience

Follow Neonatal pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it